—> Please contact us on info@pharmaplusltd.co.uk for more information

very newly qualified pharmacist joining the GPhC register is now an independent prescriber from the point of registration, under the 2021 initial education and training standards. The first wave of Day 1 IP graduates arrives this September. Every foundation trainee pharmacist working through their training year needs a Designated Prescribing Practitioner, a DPP, to sign off their prescribing competencies before they can complete it.

That single requirement, finding a DPP, is turning into the biggest bottleneck in the entire transition. A Nuffield Trust report published in April 2026 warned that DPP access varies sharply by setting and is particularly thin in community pharmacy compared to general practice or hospital. The CCA has flagged the same capacity constraint. If you employ a foundation trainee, securing their DPP is your problem to solve, not the university’s, and right now there simply are not enough DPPs to go round.

This is exactly the kind of structural gap PharmaPlus exists to close for members.

We were ahead of this. Our Independent Prescribing Transition Briefing went out to members covering the ground contractors actually need, the September 2026 IP graduate influx, the Absent Authorisation rule that came into force on 7th January 2026, IP training enrolment routes, clinical scope definition, professional indemnity review, and PMR supplier readiness for prescribing write-access. Members who read it were thinking about DPP supply before most of the sector had even registered it as a problem.

Reading about the problem is one thing. Solving it is another, and that is where PharmaPlus goes further. We actively help members find and match with a Designated Prescribing Practitioner, drawing on a working network built specifically to plug the community pharmacy gap the Nuffield Trust flagged. Rather than a contractor cold-calling their ICB primary care lead and hoping someone has capacity, PharmaPlus does the matching directly, so your trainee has a realistic route to sign-off rather than an open-ended wait.

Why this matters commercially, not just clinically

NHS England confirmed that consultation with Community Pharmacy England on a national prescribing service began in April 2026, informed by a pathfinder programme that ran over 30,000 consultations, nearly two-thirds of them for minor ailments. If a national prescribing service is commissioned, it will be the first genuine structural expansion of contractor clinical income since Pharmacy First itself. The contractors who capture that opportunity early will be the ones who already have an IP-qualified pharmacist in place, proper clinical governance behind them, and a completed DPP pathway rather than a stalled one.

The pathfinder funding has already shown what happens to sites without a clear next step. Some pathfinder services closed outright when the national funding window ended in March 2026, with no local commissioning route to fall back on. Being IP-ready without a plan for what comes next is not the same as being positioned to benefit.

What to do now, not in eighteen months’ time

The advice being handed around the sector is to start DPP conversations now and build workforce capacity roughly eighteen months ahead of need. PharmaPlus members do not have to run that clock alone. If you have a pharmacist working toward independent prescriber status, or a foundation trainee who needs sign-off, talk to us. We will help identify whether you already have a DPP-eligible pharmacist in your own team, and if not, match you with one through our network, so your route to a fully qualified, revenue-ready prescriber is a plan with a date on it, not a hope that someone locally has capacity.

—> Please contact us on info@pharmaplusltd.co.uk for more information